Novo Nordisk strikes second licensing deal since frosty capital-markets day
- Novo Nordisk: 15 events in the last 90 days
- Previous: 3 days earlier · Novo Nordisk signed a $1.3 billion deal for technology to make longer-lasting obesity shots
What happened
Novo Nordisk on Tuesday struck its second licensing deal since receiving a poor reception from investors after presenting its long-term strategy.
Summary assembled by rule from the sources below